News|Articles|February 6, 2026

7 things you need to know about the PBM reforms signed into law this week

Author(s)Denise Myshko, Peter Wehrwein, Managing Editor

PBM reform has finally made its way through Congress and was signed into law by President Donald Trump. Here are seven things you need to know about the law.

Experts and interested parties are digging into the pharmacy benefit manager (PBM) reform provisions that were included in the massive spending bill that President Donald Trump signed into law on Feb. 3. We spoke to several of them and read some (not all) of the bill’s language ourselves. Here are seven things to know to understand PBM reform.

Related to this article

November 6th, 2026

Medicare changes are here to stay. 3 ways health plans can support members through them

Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a member is changing plans or managing a new health condition, the experience should feel guided rather than overwhelming.

November 6th, 2026

Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business

Pretax adjusted income from operations from Express Scripts, Cigna's pharmacy benefit manager, fell by 21.5% compared with the third quarter of 2025, while income from operations of its specialty drug business jumped by 15%.

November 6th, 2026

'Bad data in, means bad data out'—pharmacists on the limits of AI in managed care

Annesha White, Pharm.D., M.S., Ph.D., and Fredrick Manasseh, Pharm.D., MBA, BCGP, explain where AI helps managed care pharmacy, where bias creeps in and what skills pharmacists need to oversee it.

November 6th, 2026

FDA approves Weltruza, first once-monthly subcutaneous olanzapine injection for schizophrenia

Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection monitoring required.

November 6th, 2026

Christopher Stanley, M.D., MBA, on culture change and implementing value-based care

Value-based care has scored some cost-saving successes, says Christopher Stanley, M.D., MBA, president of Henry Ford Health's Populance. Health systems that build their own value-based care strategy, rather than adopting particular models one by one, will be in the best position to succeed, he says.

November 6th, 2026

On Populance's pivot to internal customers, some early wins and the current state of value-based care | A conversation with Christopher Stanley, M.D.. MBA

The second half of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.

November 6th, 2026

On becoming a pediatrician, lessons learned in the Army and the Sutter way of doing thing | A conversation with Christopher Stanley, M.D., MBA

The first part of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and the newest member of the Managed Healthcare Executive editorial advisory board.

November 6th, 2026

Christopher Stanley, M.D., MBA, on the early population health wins of Henry Ford Health's Populance

Unifying care management doubled patient outreach with the same staff, and virtual physical therapy is cutting costs, says Populance's Christopher Stanley, M.D.